Molecules / Latanoprostene Bunod

Latanoprostene Bunod API manufacturers

CAS 860005-21-6 Updated 9 July 2026
7
manufacturers with an active filing 6 of them hold a US DMF or a CEP
11
finished-dose makers across 10 regulators
Showing 7 of 7 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

MSN Laboratories

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for latanoprostene bunod, filing since 2019. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
26 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
02

YS Life Science

South Korea
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for latanoprostene bunod, filing since 2024. Its 2025 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Chirogate International

Taiwan
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for latanoprostene bunod, filing since 2023. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Newchem

Italy
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for latanoprostene bunod, filing since 2025. Its 2023 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
05

Cayman Pharma Sro

Czech Republic
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for latanoprostene bunod, filing since 2023.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Everlight Chemical Industrial

Taiwan
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for latanoprostene bunod, filing since 2023.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
07

Registered with SFDA (Saudi Arabia) for latanoprostene bunod. Its GMP is recognised in 4 markets.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
4 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile

4 more manufacturers hold filings for latanoprostene bunod

The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.

NewchemCayman Pharma SroEverlight Chemical IndustrialChinoin Pharmaceutical And Chemical Works
Chat with Fred, your AI analyst

Finished-dose makers (3)

Gilead Sciences United States Gland Pharma India Bausch & Lomb United States

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Who makes latanoprostene bunod?

Ask Fred which manufacturers are on record for latanoprostene bunod and what filings they hold.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Also on this molecule

Finished dose 3 Contract mfrs 0